This review comprehensively summarizes the role of cytokines signaling through the JAK-STAT pathway in the pathogenesis of BP and PV, positing JAK inhibitors as a potential novel therapeutic approach for AIBD. The gene discussed is SOAT1; the disease is acquired polycythemia vera.